Novartis Pays $422.5 Million in Settlement
Thursday, September 30, 2010 - 14:28
in Mathematics & Economics
The company joins a list of drug companies that have been accused of promoting drugs for off-label purposes.
The company joins a list of drug companies that have been accused of promoting drugs for off-label purposes.
